Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Theanyl amino acid benzyl ester modified curcumin, its synthesis, activity and application

A technology of oxyacetyltheanyl and oxyacetylbenzyl ester, applied in the field of biomedicine, can solve the problems of unsatisfactory clinical curative effect of tumor chemotherapy and affecting the effect of chemotherapy

Active Publication Date: 2021-10-26
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the resistance of tumor cells to anticancer drugs during chemotherapy seriously affects the effect of chemotherapy.
Because the existing anticancer drugs do not reverse the drug resistance of tumor cells, the clinical efficacy of cancer chemotherapy is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Theanyl amino acid benzyl ester modified curcumin, its synthesis, activity and application
  • Theanyl amino acid benzyl ester modified curcumin, its synthesis, activity and application
  • Theanyl amino acid benzyl ester modified curcumin, its synthesis, activity and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Example 1 Preparation of 6-(4-hydroxyl-3-methoxyphenyl)-5,6-hexene-2,4-dione (1)

[0017] Reflux 45.0 mL (437.7 mmol) of acetylacetone, 21.0 g (301.6 mmol) of boron oxide and 150.0 mL of anhydrous ethyl acetate at 60° C. for 1 h. Then, 22.5 g (148.0 mmol) of vanillin and 41 mL (293.0 mmol) of tributyl borate were added thereto. The reaction mixture was stirred at 70 °C for 30 min. Continue to add a solution of 15 mL (205.1 mmol) of n-butylamine and 135 mL of ethyl acetate within 30 min. The mixture was stirred at 100°C for 3 h, then cooled to room temperature, and 150 mL of hydrochloric acid (1M) was added dropwise thereto. The mixture was stirred at 50°C for 30 min, allowed to stand, and the layers were fully separated, and the aqueous layer was extracted three times with ethyl acetate. The combined ethyl acetate layers were washed with saturated NaCl solution until neutral, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated to dryness unde...

Embodiment 2

[0018] Example 2 Preparation of 3-methoxy-4-(oxygen-2-acetylbenzyl)benzaldehyde (2)

[0019] Dissolve 10 g (65.8 mmol) of vanillin in 100 mL of anhydrous tetrahydrofuran. To this solution was added portionwise 10.9 g (79.0 mmol) potassium carbonate and stirred for 3 h. Then, 9.3 mL benzyl bromoacetate was added dropwise to the solution, stirred at room temperature for 48 h, and TLC monitoring (petroleum ether / ethyl acetate=3 / 1) showed that the reaction was complete. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was washed with 100 mL of ether and allowed to stand for 12 h, then poured off the ether and washed with 10 mL of ether three times to obtain 15.4 g (78%) of the title compound as a colorless solid. ESI-MS(m / e): 301[M+H] + ; 1 H NMR (300MHz, DMSO-d 6 ):δ / ppm=9.86(s,1H),7.50(dd,J 1 =8.4Hz,J 2 =1.8Hz,1H),7.44(d,J=1.8Hz,1H),7.39(s,5H),7.11(d,J=8.4Hz,1H),5.21(s,2H),5.03(s,2H ), 3.84(s,3H).

Embodiment 3

[0020] Example 3 Preparation of 1-(4-hydroxyl-3-methoxyphenyl)-7-(4-oxoacetylbenzyl-3-methoxyphenyl)-1,6-heptadiene-3, 5-diketone(3)

[0021] 5.55 g (23.7 mmol) of 6-(4-hydroxy-3-methoxyphenyl)-5,6-hexene-2,4-dione (1), 0.83 g (11.9 mmol) of boron oxide and 100 mL of acetic acid The ethyl ester suspension was refluxed at 70°C for 1h. After that, it was concentrated under reduced pressure. The residue was dissolved with 100 mL of anhydrous DMF. To the resulting solution were added 10.67 g (35.6 mmol) of 3-methoxy-4-(oxy-2-acetylbenzyl)benzaldehyde (2) and 11.15 mL (41.0 mmol) of tributyl borate. The resulting solution was stirred at 80 °C for 30 min. Afterwards, 0.98 mL (6.4 mmol) of n-butylamine was added dropwise in 4 times for 1 h, and the resulting solution was stirred at 80° C. for 3 h. After that, 200 mL of 10% aqueous acetic acid solution preheated to 60° C. was added thereto. The resulting solution was stirred for an additional 1 h at 80 °C. The reaction mixture ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses 1-(4-hydroxyl-3-methoxyphenyl)-7-(4-oxyacetyltheanyl-AA-OBzl-3-methoxyphenyl)-1,6 -Heptadiene-3,5-dione (AA in the formula is selected from L-Ile residue and L-Val residue), discloses their preparation method, discloses their anti-tumor growth activity, discloses their Reversing the drug resistance activity of tumor cells, thus the invention discloses their application in preparing anti-tumor drugs and reversing drug resistance of tumor cells.

Description

technical field [0001] The present invention relates to 1-(4-hydroxy-3-methoxyphenyl)-7-(4-oxoacetyltheanyl-AA-OBzl-3-methoxyphenyl)-1,6-heptadiene -3,5-dione. It relates to their preparation method, their anti-tumor growth activity, and their activity of reversing tumor cell drug resistance, so the present invention relates to their application in preparing anti-tumor drugs and reversing tumor cell drug resistance. The invention belongs to the field of biomedicine. Background technique [0002] Malignant tumors are a global problem that seriously endangers human health. Cancer patients are mostly in the middle and late stages when they are discovered. The main treatment methods are radiotherapy and chemotherapy. Chemotherapy is the main treatment for malignant tumors in the middle and late stages. However, the resistance of tumor cells to antitumor drugs during chemotherapy seriously affects the effect of chemotherapy. Because the existing antitumor drugs do not reverse...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K5/062A61K38/05A61P35/00
CPCA61K38/00C07K5/06034C07K5/06052
Inventor 赵明彭师奇王玉记吴建辉王安航
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com